Liam utilised BioInnovate along with his peers Wayne Allen and Colin Forde to progress with a concept of single shot reliable embolisation and obtained both Enterprise Ireland Commercial Funding and €3 million in Series A funding from Enterprise Ireland and AIB’s Seed Capital Fund to create BioInnovate’s first spin out company, Embo Medical. Between mid-2012 and August 2016 Liam acted as Embo Medical’s CTO. In 2016 Embo Medical was acquired by CR Bard’s subsidiary Clearstream for almost €43.5 million. Following the acquisition completion, Liam now acts as CTO for a new startup NeuVT.